Search Results - "DePorter, Sandra M."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Engineered M13 Bacteriophage Nanocarriers for Intracellular Delivery of Exogenous Proteins to Human Prostate Cancer Cells by DePorter, Sandra M, McNaughton, Brian R

    Published in Bioconjugate chemistry (17-09-2014)
    “…The size, well-defined structure, and relatively high folding energies of most proteins allow them to recognize disease-relevant receptors that present a…”
    Get full text
    Journal Article
  2. 2

    N-Nosyl oxaziridines as terminal oxidants in copper(II)-catalyzed olefin oxyaminations by DePorter, Sandra M., Jacobsen, Ashley C., Partridge, Katherine M., Williamson, Kevin S., Yoon, Tehshik P.

    Published in Tetrahedron letters (06-10-2010)
    “…We report that N-4-nosyl-3-phenyloxaziridine is an effective terminal oxidant for copper(II)-catalyzed oxyamination recently developed in our labs. This…”
    Get full text
    Journal Article
  3. 3

    A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer Cells by Gray, Melissa A., Tao, Ran N., DePorter, Sandra M., Spiegel, David A., McNaughton, Brian R.

    “…We report a rationally designed nanobody activation immunotherapeutic that selectively redirects anti‐dinitrophenyl (anti‐DNP) antibodies to the surface of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Back Cover: A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer Cells (ChemBioChem 2/2016) by Gray, Melissa A., Tao, Ran N., DePorter, Sandra M., Spiegel, David A., McNaughton, Brian R.

    “…The back cover picture shows a killer nanobody. Features unique to proteins allow these biomolecules to recognize disease‐relevant structures that challenge or…”
    Get full text
    Journal Article
  6. 6

    Mutagenesis modulates the uptake efficiency, cell-selectivity, and functional enzyme delivery of a protein transduction domain by DePorter, Sandra M, Lui, Irene, Bruce, Virginia J, Gray, Melissa A, Lopez-Islas, Monica, McNaughton, Brian R

    Published in Molecular bioSystems (01-01-2014)
    “…Alanine scanning mutagenesis of a recently reported prostate cancer cell-selective Protein Transduction Domain (PTD) was used to assess the specific…”
    Get more information
    Journal Article
  7. 7

    A Protein Transduction Domain with Cell Uptake and Selectivity Profiles that Are Controlled by Multivalency Effects by DePorter, Sandra M., Lui, Irene, Mohan, Utpal, McNaughton, Brian R.

    Published in Chemistry & biology (21-03-2013)
    “…Protein transduction domains (PTDs) are reagents that facilitate the delivery of diverse cargo to the interior of mammalian cells. We identified a PTD called…”
    Get full text
    Journal Article
  8. 8

    A one-pot synthesis of micron-sized and nanoscale poly(N-acryloxysuccinimide-co-N-vinylpyrrolidone) particles by DePorter, Sandra M., Hendricks, Noah K., Gray, Melissa A., McNaughton, Brian R.

    Published in Tetrahedron letters (21-11-2012)
    “…We report a one-pot synthesis of well-defined micron-sized or nanoscale poly(N-acryloxysuccinimide-co-N-vinylpyrrolidone) particles. We show that these…”
    Get full text
    Journal Article
  9. 9

    Engineering bacteriophage nanocarriers for targeted delivery of protein reagents to prostate cancer cells by DePorter, Sandra M

    Published 01-01-2014
    “…Proteinaceous reagents, including antibodies and synthetic proteins, have become some of the most effective reagents for targeted treatment and diagnosis of…”
    Get full text
    Dissertation